The EPS projection of NuVasive, Inc. (NASDAQ:NUVA) for quarter ended 2016-09-30 is $0.38. A week before, the EPS forecast was $0.38 against target of $0.38, a month earlier. This estimate stood at $0.38 60 days earlier versus forecast of $0.38 90 days earlier, confirming a deviation of 0%.
NuVasive, Inc. (NASDAQ:NUVA) reported that 18 days ago, the positive EPS revisions were 5 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 0, 0 and 0, respectively.
The downgrade of EPS estimates for NuVasive, Inc. (NASDAQ:NUVA) in the preceding 120, 60, 30 and 90 days were 6, 6, 0 and 6, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of NuVasive, Inc. (NASDAQ:NUVA) was $0.38. This projection was computed after accounting 11 calls. As reported on 2016-04-26 the EPS was $0.32. The change was $0.05, demonstrating a percentage deviation of 18.52%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for NuVasive, Inc. (NASDAQ:NUVA) stands at $269.782 and the median estimate at $269.782. Almost 2 analysts announced their estimates.
The highest estimate is $273.295 while the lowest target is $266.27 showing standard deviation of 4.967%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. NuVasive, Inc. (NASDAQ:NUVA) stated that the change in forecast was -0.088%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...